The GlycoMark Test:
A simpler, smarter way to uncover hyperglycemia.
Know more. Do more.
The clinically proven, FDA cleared GlycoMark test measures the 1,5-anhydroglucitol molecule in the blood, providing an accurate picture of recent glycemic variability that A1C, fasting glucose and other tests can’t. GlycoMark gives a more complete and current picture of your patient’s glycemic profile.
GlycoMark tells you what
you don’t know now.
A sustained, effective strategy of blood glucose management incorporates complementary testing procedures. A1C is a long-term average. Fructosamine is an intermediate-term average. Fasting glucose is an immediate measure. Only the GlycoMark test is a specific indicator of recent occurrences of hyperglycemia and glycemic variability.
GlycoMark reveals recent
Glycemic variability is a challenge for diabetes management. Studies show that nearly 40% of patients who are considered to be in good control of their diabetes may suffer significant glucose fluctuations that don’t show up in an A1C average. By identifying more recent occurrences of glycemic variability, the GlycoMark test tells you what A1C cannot.